These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
108 related items for PubMed ID: 7841433
1. Quantitation of mycobacteria in blood specimens from patients with AIDS. Sanchez T, Vanderkolk J, Seay S, Heifets L. Tuber Lung Dis; 1994 Oct; 75(5):386-90. PubMed ID: 7841433 [Abstract] [Full Text] [Related]
2. Successful short-term suppression of clarithromycin-resistant Mycobacterium avium complex bacteremia in AIDS. California Collaborative Treatment Group. Dubé MP, Torriani FJ, See D, Havlir DV, Kemper CA, Leedom JM, Tilles JG, McCutchan JA, Sattler FR. Clin Infect Dis; 1999 Jan; 28(1):136-8. PubMed ID: 10028084 [Abstract] [Full Text] [Related]
3. Clarithromycin or rifabutin alone or in combination for primary prophylaxis of Mycobacterium avium complex disease in patients with AIDS: A randomized, double-blind, placebo-controlled trial. The AIDS Clinical Trials Group 196/Terry Beirn Community Programs for Clinical Research on AIDS 009 Protocol Team. Benson CA, Williams PL, Cohn DL, Becker S, Hojczyk P, Nevin T, Korvick JA, Heifets L, Child CC, Lederman MM, Reichman RC, Powderly WG, Notario GF, Wynne BA, Hafner R. J Infect Dis; 2000 Apr; 181(4):1289-97. PubMed ID: 10762562 [Abstract] [Full Text] [Related]
4. Comparison of clarithromycin-sensitive and clarithromycin-resistant Mycobacterium avium strains isolated from AIDS patients during therapy regimens including clarithromycin. Matsiota-Bernard P, Zinzendorf N, Onody C, Guenounou M. J Infect; 2000 Jan; 40(1):49-54. PubMed ID: 10762111 [Abstract] [Full Text] [Related]
5. A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. Canadian HIV Trials Network Protocol 010 Study Group. Shafran SD, Singer J, Zarowny DP, Phillips P, Salit I, Walmsley SL, Fong IW, Gill MJ, Rachlis AR, Lalonde RG, Fanning MM, Tsoukas CM. N Engl J Med; 1996 Aug 08; 335(6):377-83. PubMed ID: 8676931 [Abstract] [Full Text] [Related]
6. A randomized trial of clarithromycin as prophylaxis against disseminated Mycobacterium avium complex infection in patients with advanced acquired immunodeficiency syndrome. Pierce M, Crampton S, Henry D, Heifets L, LaMarca A, Montecalvo M, Wormser GP, Jablonowski H, Jemsek J, Cynamon M, Yangco BG, Notario G, Craft JC. N Engl J Med; 1996 Aug 08; 335(6):384-91. PubMed ID: 8663871 [Abstract] [Full Text] [Related]
7. Correlation of quantitative bone marrow and blood cultures in AIDS patients with disseminated Mycobacterium avium complex infection. Hafner R, Inderlied CB, Peterson DM, Wright DJ, Standiford HC, Drusano G, Muth K. J Infect Dis; 1999 Aug 08; 180(2):438-47. PubMed ID: 10395860 [Abstract] [Full Text] [Related]
8. Rifabutin for MAC questioned. Posit Aware; 1995 Aug 08; ():6. PubMed ID: 11362571 [Abstract] [Full Text] [Related]
10. Type frequency and antimicrobial susceptibility of Mycobacterium avium-intracellulare complex strains isolated in Italy from AIDS and non-AIDS patients. Fattorini L, Vincent V, Li B, Xiao Y, Varnerot A, Tortoli E, Piersimoni C, Mandler F, Mascellino MT, Iona E, Orefici G. J Chemother; 1996 Feb 08; 8(1):37-42. PubMed ID: 8835106 [Abstract] [Full Text] [Related]
11. A prospective randomized trial of four three-drug regimens in the treatment of disseminated Mycobacterium avium complex disease in AIDS patients: excess mortality associated with high-dose clarithromycin. Terry Beirn Community Programs for Clinical Research on AIDS. Cohn DL, Fisher EJ, Peng GT, Hodges JS, Chesnut J, Child CC, Franchino B, Gibert CL, El-Sadr W, Hafner R, Korvick J, Ropka M, Heifets L, Clotfelter J, Munroe D, Horsburgh CR. Clin Infect Dis; 1999 Jul 08; 29(1):125-33. PubMed ID: 10433575 [Abstract] [Full Text] [Related]
12. Quantitative cultures and drug susceptibility testing of Mycobacterium avium clinical isolates before and during the antimicrobial therapy. Heifets LB. Res Microbiol; 1994 Jul 08; 145(3):188-96. PubMed ID: 7809471 [No Abstract] [Full Text] [Related]
13. [Ubiquitous mycobacteria: clinical and microbiological aspects]. Schütt-Gerowitt H. Med Klin (Munich); 1996 Oct 15; 91(10):654-9. PubMed ID: 9019643 [No Abstract] [Full Text] [Related]
14. Postantibiotic effect of clarithromycin alone and combined with ethambutol against Mycobacterium avium complex. Ellis LC, Benson CA, Koenig GI, Trenholme GM. Antimicrob Agents Chemother; 1995 Dec 15; 39(12):2803-6. PubMed ID: 8593025 [Abstract] [Full Text] [Related]
15. In vitro and in vivo synergistic effect of isoniazid with streptomycin and clofazimine against Mycobacterium avium complex (MAC). Reddy MV, Srinivasan S, Gangadharam PR. Tuber Lung Dis; 1994 Jun 15; 75(3):208-12. PubMed ID: 7919314 [Abstract] [Full Text] [Related]
16. [A case of acquired immunodeficiency syndrome with disseminated Mycobacterium avium complex infection in which M. avium was isolated from bone marrow]. Ohse H, Saito T, Kadono K, Hirano K, Watanabe S, Nemoto E, Fukai S, Yanai N, Ishii Y, Hasegawa S. Kekkaku; 1997 Feb 15; 72(2):73-7. PubMed ID: 9071089 [Abstract] [Full Text] [Related]
17. Mycobacterium avium strains resistant to clarithromycin and azithromycin. Wolinsky E. Antimicrob Agents Chemother; 1994 Mar 15; 38(3):635. PubMed ID: 8031406 [No Abstract] [Full Text] [Related]
18. Electron microscopic analysis of Mycobacterium avium complex isolates exposed to ciprofloxacin, rifabutin, ethambutol and clarithromycin. Reisner BS, Woods GL, Popov VL. Int J Tuberc Lung Dis; 1997 Jun 15; 1(3):270-5. PubMed ID: 9432376 [Abstract] [Full Text] [Related]